Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among Plasmodium falciparum Isolates on Bioko Island, Equatorial Guinea: 2011–2017

References

• World malaria report; 2019 Available from: https://www.who.int/news-room/feature-stories/detail/world-malaria-report-2019. Accessed 326, 2020.
   Google Scholar
• Grais RF, Laminou IM, Woi-Messe L, et al. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger. Malar J. 2018;17(1):98. doi:10.1186/s12936-018-2242-429486766
   PubMed Web of Science ®Google Scholar
• Ruizendaal E, Tahita MC, Geskus RB, et al. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso. Malar J. 2017;16(1):179. doi:10.1186/s12936-017-1831-y28454537
   PubMed Web of Science ®Google Scholar
• Guerra M, de Sousa B, Ndong-Mabale N, Berzosa P, Arez AP. Malaria determining risk factors at the household level in two rural villages of mainland Equatorial Guinea. Malar J. 2018;17(1):203. doi:10.1186/s12936-018-2354-x29776367
   PubMed Web of Science ®Google Scholar
• Tessema SK, Kassa M, Kebede A, et al. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of sulfadoxine-pyrimethamine in North Western Ethiopia. PLoS One. 2015;10(10):e0126943. doi:10.1371/journal.pone.012694326431464
   PubMed Web of Science ®Google Scholar
• Nkoli Mandoko P, Rouvier F, Matendo Kakina L, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine-pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant Pfdhfr/Pfdhps alleles. J Antimicrob Chemother. 2018;73(10):2704–2715. doi:10.1093/jac/dky25830053021
   PubMed Web of Science ®Google Scholar
• Li J, Chen J, Xie D, et al. Molecular mutation profile of Pfcrt and Pfmdr1 in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Infect Genet Evol. 2015;36:552–556. doi:10.1016/j.meegid.2015.08.03926325683
   PubMed Web of Science ®Google Scholar
• Li J, Chen J, Xie D, et al. High prevalence of Pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Pathog Glob Health. 2014;108(7):339–343. doi:10.1179/2047773214Y.000000015825348116
   PubMed Web of Science ®Google Scholar
• Guerra M, Neres R, Salgueiro P, et al. Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy. Antimicrob Agents Chemother. 2017;61(1).
   Google Scholar
• Benito A, Roche J, Molina R, Amela C, Alvar J. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine-pyrimethamine in Equatorial Guinea. Am J Trop Med Hyg. 1995;53(5):526–531. doi:10.4269/ajtmh.1995.53.5267485712
   PubMed Web of Science ®Google Scholar
• Charle P, Berzosa P, de Lucio A, Raso J, Nseng Nchama G, Benito A. Artesunate/amodiaquine malaria treatment for Equatorial Guinea (Central Africa). Am J Trop Med Hyg. 2013;88(6):1087–1092. doi:10.4269/ajtmh.12-029023530078
   PubMed Web of Science ®Google Scholar
• Berzosa P, Esteban-Cantos A, Garcia L, et al. Profile of molecular mutations in Pfdhfr, Pfdhps, Pfmdr1, and Pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea). Malar J. 2017;16(1):28. doi:10.1186/s12936-016-1672-028086777
   PubMed Web of Science ®Google Scholar
• Manore CA, Teboh-Ewungkem MI, Prosper O, Peace A, Gurski K, Feng Z. Intermittent Preventive Treatment (IPT): its role in averting disease-induced mortality in children and in promoting the spread of antimalarial drug resistance. Bull Math Biol. 2019;81(1):193–234. doi:10.1007/s11538-018-0524-130382460
   PubMed Web of Science ®Google Scholar
• Spalding MD, Eyase FL, Akala HM, et al. Increased prevalence of the Pfdhfr/phdhps quintuple mutant and rapid emergence of Pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J. 2010;9(1):338. doi:10.1186/1475-2875-9-33821106088
   PubMed Web of Science ®Google Scholar
• Mohamed AO, Hussien M, Mohamed A, et al. Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan. Malar J. 2020;19(1):78. doi:10.1186/s12936-020-03165-032070355
   PubMed Web of Science ®Google Scholar
• Osarfo J, Tagbor H, Magnussen P, Alifrangis M. Molecular markers of Plasmodium falciparum drug resistance in parasitemic pregnant women in the middle forest belt of Ghana. Am J Trop Med Hyg. 2018;98(6):1714–1717. doi:10.4269/ajtmh.18-000929582732
   PubMed Web of Science ®Google Scholar
• McCollum AM, Schneider KA, Griffing SM, et al. Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya. Malar J. 2012;11(1):77. doi:10.1186/1475-2875-11-7722439637
   PubMed Web of Science ®Google Scholar
• Artimovich E, Kapito-Tembo A, Pensulo P, et al. The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi. Malar J. 2015;14(1):387. doi:10.1186/s12936-015-0860-726437774
   PubMed Web of Science ®Google Scholar
• Artimovich E, Schneider K, Taylor TE, et al. Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. J Infect Dis. 2015;212(5):694–701. doi:10.1093/infdis/jiv07825672905
   PubMed Web of Science ®Google Scholar
• Jiang T, Chen J, Fu H, et al. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. Malar J. 2019;18(1):101. doi:10.1186/s12936-019-2734-x30914041
   PubMed Web of Science ®Google Scholar
• Cook J, Hergott D, Phiri W, et al. Trends in parasite prevalence following 13 years of malaria interventions on Bioko island, Equatorial Guinea: 2004–2016. Malar J. 2018;17(1):62. doi:10.1186/s12936-018-2213-929402288
   PubMed Web of Science ®Google Scholar
• Malaria Control and Elimination. Available from: https://www.mcdinternational.org/bimcp. Accessed 326, 2020.
   Google Scholar
• Wang SQ, Zhou HY, Li Z, et al. Quantitative detection and species identification of human Plasmodium spp. by using SYBR Green I based real-time PCR. Zhong Guo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011;23(6):677–681.
   Google Scholar
• Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 1999;16(1):37–48. doi:10.1093/oxfordjournals.molbev.a02603610331250
   PubMed Web of Science ®Google Scholar
• Leigh JW, Bryant D, Nakagawa S, Nakagawa S. Popart: full-feature software for haplotype network construction. Methods Ecol Evol. 2015;6(9):1110–1116. doi:10.1111/mee3.2015.6.issue-9
   Web of Science ®Google Scholar
• Yao Y, Wu K, Xu M, et al. Surveillance of genetic variations associated with antimalarial resistance of Plasmodium falciparum isolates from returned migrant workers in Wuhan, Central China. Antimicrob Agents Chemother. 2018;62(9). doi:10.1128/AAC.02387-17.
   Web of Science ®Google Scholar
• Bai Y, Zhang J, Geng J, et al. Longitudinal surveillance of drug resistance in Plasmodium falciparum isolates from the China-Myanmar border reveals persistent circulation of multidrug resistant parasites. Int J Parasitol Drugs Drug Resist. 2018;8(2):320–328. doi:10.1016/j.ijpddr.2018.05.00329793059
   PubMed Web of Science ®Google Scholar
• Bamaga OA, Mahdy MA, Lim YA. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen. Malar J. 2015;14(1):516. doi:10.1186/s12936-015-1035-226693691
   PubMed Web of Science ®Google Scholar
• Baraka V, Delgado-Ratto C, Nag S, et al. Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo. Int J Antimicrob Agents. 2017;49(4):456–464. doi:10.1016/j.ijantimicag.2016.12.00728237831
   PubMed Web of Science ®Google Scholar
• Barnadas C, Timinao L, Javati S, et al. Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea. Malar J. 2015;14(1):399. doi:10.1186/s12936-015-0879-926452541
   PubMed Web of Science ®Google Scholar
• Basuki S, Fitriah RS, Budiono DYP, Uemura H. Two novel mutations of Pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia. Malar J. 2014;13(1):135. doi:10.1186/1475-2875-13-13525187019
   PubMed Web of Science ®Google Scholar
• Bwijo B, Kaneko A, Takechi M, et al. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop. 2003;85(3):363–373. doi:10.1016/S0001-706X(02)00264-412659974
   PubMed Web of Science ®Google Scholar
• Chauvin P, Menard S, Iriart X, et al. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine-pyrimethamine in pregnant women in Yaounde, Cameroon: emergence of highly resistant Pfdhfr/Pfdhps alleles. J Antimicrob Chemother. 2015;70(9):2566–2571. doi:10.1093/jac/dkv16026080363
   PubMed Web of Science ®Google Scholar
• Das MK, Chetry S, Kalita MC, Dutta P. Evidence of triple mutant Pfdhps ISGNGA haplotype in Plasmodium falciparum isolates from North-east India: an analysis of sulfadoxine resistant haplotype selection. Genom Data. 2016;10:144–150. doi:10.1016/j.gdata.2016.11.00127872816
   PubMedGoogle Scholar
• Kaingona-Daniel EP, Gomes LR, Gama BE, et al. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola. Malar J. 2016;15(1):309. doi:10.1186/s12936-016-1358-727267365
   PubMed Web of Science ®Google Scholar
• Lucchi NW, Okoth SA, Komino F, et al. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya. Antimicrob Agents Chemother. 2015;59(7):3995–4002. doi:10.1128/AAC.04961-1425896703
   PubMed Web of Science ®Google Scholar
• Voumbo-Matoumona DF, Kouna LC, Madamet M, Maghendji-Nzondo S, Pradines B, Lekana-Douki JB. Prevalence of Plasmodium falciparum antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014. Infect Drug Resist. 2018;11:1329–1338. doi:10.2147/IDR.S16016430214253
   PubMed Web of Science ®Google Scholar
• Oboh MA, Singh US, Antony HA, et al. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite Plasmodium falciparum in southwestern Nigeria. Infect Genet Evol. 2018;66:222–228. doi:10.1016/j.meegid.2018.10.00730316883
   PubMed Web of Science ®Google Scholar
• Rouhani M, Zakeri S, Pirahmadi S, Raeisi A, Djadid ND. High prevalence of Pfdhfr-Pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran. Infect Genet Evol. 2015;31:183–189. doi:10.1016/j.meegid.2015.01.02025653131
   PubMed Web of Science ®Google Scholar
• Ranjitkar S, Schousboe ML, Thomsen TT, et al. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal. Malar J. 2011;10(1):75. doi:10.1186/1475-2875-10-7521457533
   PubMed Web of Science ®Google Scholar
• Ruh E, Bateko JP, Imir T, Taylan-Ozkan A. Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo. Malar J. 2018;17(1):17. doi:10.1186/s12936-017-2160-x29316929
   PubMed Web of Science ®Google Scholar
• Morton LC, Huber C, Okoth SA, et al. Plasmodium falciparum drug-resistant haplotypes and population structure in postearthquake Haiti, 2010. Am J Trop Med Hyg. 2016;95(4):811–816. doi:10.4269/ajtmh.16-021427430541
   PubMed Web of Science ®Google Scholar
• Okell LC, Griffin JT, Roper C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci Rep. 2017;7(1):7389. doi:10.1038/s41598-017-06708-928785011
   PubMed Web of Science ®Google Scholar
• Naidoo I, Roper C. Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria. Trends Parasitol. 2013;29(10):505–515. doi:10.1016/j.pt.2013.08.00224028889
   PubMed Web of Science ®Google Scholar